Q3 Earnings Forecast for Waters Issued By Leerink Partnrs

Waters Co. (NYSE:WAT) – Analysts at Leerink Partnrs decreased their Q3 2025 earnings per share estimates for Waters in a report issued on Tuesday, May 6th. Leerink Partnrs analyst P. Souda now forecasts that the medical instruments supplier will earn $3.22 per share for the quarter, down from their previous forecast of $3.23. The consensus estimate for Waters’ current full-year earnings is $12.86 per share. Leerink Partnrs also issued estimates for Waters’ Q4 2025 earnings at $4.49 EPS and FY2026 earnings at $14.32 EPS.

Several other research firms have also recently weighed in on WAT. Barclays cut their price objective on Waters from $400.00 to $350.00 and set an “equal weight” rating on the stock in a report on Thursday, April 10th. KeyCorp upgraded shares of Waters from a “sector weight” rating to an “overweight” rating and set a $460.00 price objective on the stock in a research note on Monday, March 31st. Robert W. Baird upped their price target on shares of Waters from $355.00 to $374.00 and gave the company an “outperform” rating in a research note on Wednesday. Scotiabank upgraded shares of Waters from a “sector perform” rating to a “sector outperform” rating and lifted their price target for the company from $430.00 to $450.00 in a research report on Thursday, February 13th. Finally, JPMorgan Chase & Co. upped their target price on Waters from $380.00 to $390.00 and gave the stock a “neutral” rating in a research note on Thursday, March 6th. Ten research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Waters presently has a consensus rating of “Moderate Buy” and a consensus price target of $390.19.

Waters Stock Down 2.0 %

NYSE:WAT opened at $343.73 on Friday. Waters has a 1 year low of $279.24 and a 1 year high of $423.56. The stock has a 50-day moving average price of $349.55 and a two-hundred day moving average price of $370.12. The stock has a market cap of $20.45 billion, a price-to-earnings ratio of 32.09, a PEG ratio of 3.79 and a beta of 1.14. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.03. Waters had a return on equity of 46.31% and a net margin of 21.56%. The firm had revenue of $661.71 million for the quarter, compared to analysts’ expectations of $655.50 million. During the same quarter last year, the business earned $2.21 earnings per share. The company’s revenue was up 3.9% compared to the same quarter last year.

Institutional Trading of Waters

Large investors have recently bought and sold shares of the business. Olde Wealth Management LLC acquired a new stake in Waters in the first quarter valued at approximately $25,000. Aster Capital Management DIFC Ltd purchased a new stake in Waters during the fourth quarter valued at about $28,000. IFP Advisors Inc boosted its holdings in shares of Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 44 shares during the period. Bank of Jackson Hole Trust purchased a new position in Waters during the fourth quarter valued at approximately $34,000. Finally, Fortitude Family Office LLC grew its position in Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 66 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.